echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Lancet Sub-Journal: Routine use of levothyroxine does not improve live birth rates in euthyroid TPO-Ab-positive women with recurrent miscarriage

    Lancet Sub-Journal: Routine use of levothyroxine does not improve live birth rates in euthyroid TPO-Ab-positive women with recurrent miscarriage

    • Last Update: 2022-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Thyroid peroxidase antibody (TPO-Ab)-positive women have a higher risk of recurrent miscarriage than the general population
    .


    It is not known whether levothyroxine therapy improves pregnancy outcomes in women who are TPO-Ab positive and have a history of recurrent miscarriage


    The purpose of this study (T4LIFE) was to determine whether levothyroxine increases live birth rates in TPO-Ab-positive women with a history of recurrent miscarriage and euthyroidism
    .

    This is an international, double-blind, placebo-controlled Phase 3 trial recruiting TPO-Ab-positive women aged 18-42, with ≥2 miscarriages, with normal thyroid stimulating hormone (TSH) levels, and excluded Antiphospholipid syndrome, other autoimmune diseases, thyroid disease patients
    .


    Patients were randomized 1:1 into two groups to receive oral levothyroxine (0.


    Live birth rates in both groups

    Live birth rates in both groups

    Between January 1, 2013, and September 19, 2019, a total of 187 women were recruited: 94 (50%) were assigned to levothyroxine and 93 (50%) were assigned to placebo
    .


    47 (50%) and 45 (48%) women in the levothyroxine and placebo groups, respectively, delivered their newborns successfully (hazard ratio 1.


    187 Forty-seven (50%) and 45 (48%) women in the levothyroxine and placebo groups, respectively , delivered their newborns successfully (hazard ratio 1.


    Levothyroxine did not increase the live birth rate compared with placebo in TPO-Ab-positive euthyroid women with a history of recurrent miscarriage Live birth rates in euthyroid women with a history of recurrent miscarriage TPO-Ab positive euthyroid women with a history of recurrent miscarriage

     

    Original source:

    Original source:

    Myrthe M van Dijk, et al.


    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.